We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Rajiv R. Srivastava
Rajiv R. Srivastava
Products
PRODUCTS
Ipca Laboratories Ltd.
Kellia N. Hicks
and
Rajiv R. Srivastava
Price:
$117.00
View
Global Pharma Healthcare Pvt. Ltd.
Eileen A. Liu
and
Rajiv R. Srivastava
Price:
$117.00
View
Jubilant Generics Ltd.
Yvins Dezan
and
Rajiv R. Srivastava
Price:
$117.00
View
Lupin Ltd.
Rajiv R. Srivastava
Price:
$117.00
View
Chemeca Drus Private Ltd.
Rajiv R. Srivastava
Price:
$117.00
View
Macleods Pharmaceuticals Ltd.
Dipesh Shah
and
Rajiv R. Srivastava
Price:
$117.00
View
Teva API India Pvt. Ltd.
Dipesh Shah
,
Rajiv R. Srivastava
, and
Anita Tiwari
Price:
$117.00
View
Yash Pharmaceuticals
Letitia Robinson
and
Rajiv R. Srivastava
Price:
$117.00
View
Asept Pak, Inc.
Rajiv R. Srivastava
Price:
$117.00
View
Teva API India Pvt., Ltd.
Dipesh Shah
,
Rajiv R. Srivastava
, and
Anita Tiwari
Price:
$117.00
View
View All Products by Rajiv R. Srivastava
Upcoming Events
28
Mar
The Inflation Reduction Act (IRA): How Will It Impact Drug Development?
04
Apr
Managing Data and Documentation for FDA Inspections and Remote Assessments
11
Apr
Integrating Regulatory Intelligence into Supplier Management
14
Apr
MAGI 2024: The Clinical Research Conference
25
Apr
A Masterclass on Effective 483 Responses
14
May
2024 Avoca Quality Consortium Summit
Featured Products
FDA, FTC and DOJ Enforcement of Medical Device Regulations
Using Real-World Evidence in Drug and Device Submissions
Featured Stories
FDA Approves First Oral Nonsteroidal Drug for Duchenne
FTC Continues Battle to Force Teva to Delist Patents From Orange Book
CDER Establishes New Quantitative Medicine Center of Excellence
Embracing, Expanding Sterilization Standards Endorsed in FDA Webinar
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More